- Bob Dagher, MD, Promoted to Chief Medical Officer
- Dr. Stacy Lindborg Stepping Down as Co-CEO and Transitioning to Board of Directors
Reported Earlier, BrainStorm Cell Therapeutics Announces Management Changes As It Plans Registrational Phase 3b Trial Of NurOwn
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.